Current affiliation: Fudan UniversitySubject: Medicine And Medical SciencesPrimary location: China, People's Republic of
Published in:International Journal of NanomedicinePublication date:2015-10-01
Background and Objectives Gemcitabine is far from satisfaction as the 1st line regimen for pancreatic cancer, the emerging albumin nanoparticles br...
Published in:Scientific ReportsPublication date:2016-08-12
Published in:Oncology LettersPublication date:2015-06-30
Published in:International Journal of NanomedicinePublication date:2017-09-01